Evidence map›Paper›PMID 39954233›Full record

ArticleClinical and translational science2025

Participant-Centered Engagement for Sustained Adherence to Smartwatches: A 12-Month Prospective Decentralized Digital Health Study.

Angelina R Wilton, Christina T Saliba, Jean Marrero-Polanco, Katharine Sheffield, Quantia Wilkes, Miriam Anacker, Paul E Croarkin, Mohit Chauhan, Liselotte N Dyrbye, Sherry Chesak and 2 more

Abstract read
In one paragraph

Article in Clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Angelina R WiltonDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0009-0001-7817-6765
Christina T SalibaDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0009-0005-9180-8025
Jean Marrero-PolancoDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2232-0788
Katharine SheffieldDepartment of Nursing, Mayo Clinic, Jacksonville, Florida, USA.
Quantia WilkesCenter for Individualized Medicine, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0009-0000-8119-1803
Miriam AnackerCenter for Individualized Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6843-6503
Mohit ChauhanDepartment of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0001-8848-4385
Liselotte N DyrbyeDepartment of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.ORCID 0000-0002-7820-704X
Sherry ChesakDepartment of Nursing, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-8126-4486
William V BoboCenter for Individualized Medicine, Mayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0002-5674-3079
Arjun P AthreyaDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-9764-1768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adherence in digital health studies with extended observation periods (≥ 12 months) is limited, and participant retention considerably reduces with time. The US Food and Drug Administration has issued guidelines for improving participant engagement, adherence, and diversity in digital health studies combined with decentralized procedures. A decentralized digital health study on well-being was designed with protocolized procedures to study the feasibility of participant engagement and technology support to facilitate adherence (wearing the smartwatch ≥ 70% of time) sustained over a 12-month period. At the end of the study, participants were asked about their ease of participation and free-response questions about how wearing the smartwatches impacted their physical wellness. An inductive thematic analysis (ITA) was performed to assess themes of those responses and association with adherence. A total of 298 participants were recruited between 2022 and 2023 (n = 129 in Cohort A in October 22, n = 169 in Cohort B in April 23), with 23% non-white participants accrued. Among the 298 participants accrued, 273 (92% of accrued participants) completed the 12-month study with an average overall adherence of 77.4% (SD = 32.64) wear-time across 12 months. Median adherence of participants whose responses exemplified an ITA theme encompassing perceived behavior changes in sleep and physical activity was higher than those who did not have a response exemplifying that theme. Conversely, those expressing perceived discomfort or intrusiveness of the smartwatch had a statistically lower adherence. These results highlight the crucial roles of technology support and robust engagement efforts to enable sustained adherence over extended follow-up periods in decentralized digital health studies.

Indexed as

Patient CompliancePatient ParticipationWearable Electronic DevicesAdultAgedDigital HealthFeasibility StudiesFemaleHumansMaleMiddle AgedProspective StudiesTelemedicineUnited Statesdecentralized studydigital healthengagementsmartwatchwellness

Identifiers

PMID39954233
PMCPMC11829698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.